Skip to main content
. Author manuscript; available in PMC: 2016 Mar 30.
Published in final edited form as: Mol Psychiatry. 2014 Feb 11;19(11):1186–1192. doi: 10.1038/mp.2014.2

Table 1.

Patients’ clinical details

N Target Diagnosis Center Age Sex Disease duration BDI a HAM-D b YBOCSb/comorbid depression Medication
1 CG25 MDD Berlin 49 F 33 35 22 NA Loracepam, amitriptyline, quetiapine, topiramate
2 CG25 MDD Berlin 61 F 23 22 23 NA Loracepam, clomipramine, fluvoxamine, lithium, gabapentine, mirtazapine
3 CG25 MDD Berlin 48 F 16 46 30 NA Lithium, quetiapine, duloxetine
4 CG25 MDD Berlin 60 F 20 36 34 NA Lithium, tranylcypromine, pregabaline, quetiapine
5 CG25 MDD Berlin 36 M 16 57 24 NA No medication
6 CG25 MDD Berlin 50 M 34 41 32 NA Zopiclone, quetiapine, trimipramine
7 CG25 MDD Berlin 55 M 20 37 21 NA Pregabalin, agomelatine, quetiapine, levothyroxine
8 BNST MDD Leuven 58 M 34 10 21 NA Reboxetine, zoplicone, clorazepat, allopurinol, trazodone
9 BNST MDD Leuven 42 F 25 32 27 NA Lormetazepam, venlafaxine, lorazepam, promethiazine, trazodone, elthyrone
10 BNST MDD Leuven 51 F 5 17 27 NA No medication
11 BNST MDD Leuven 55 M 11 14 21 NA Venlafaxine RT, lithiumcarbonate
12 BNST MDD Leuven 45 M 9 44 23 NA Clomipramine, trazodone, lithiumcarbonate
13 BNST MDD Leuven 46 M 9 6 26 NA Duloxetine
14 BNST MDD Leuven 50 F 14 5 25 NA Aripiprazole, clomipramine, lithiumcarbonate, trazodone, lormetazepam, simvastatine
15 BNST OCD Leuven 32 M 17 20 21 32/No Clomipramine, quetiapine, fluvoxamine, clonazepam
16 BNST OCD Leuven 52 M 34 10 27 35/Yes Prazepam
17 BNST OCD Leuven 60 M 52 NA 29 36/Yes Buspirone, fluvoxamine, clonazepam
18 BNST OCD Leuven 51 F 33 35 14 37/Yes Alprazolam
19 BNST OCD Leuven 34 M 22 10 20 37/No Bisoprolol, melatonine, alprazolam

Abbreviations: BDI, Beck depression inventory; BNST, bed nucleus of stria terminali; F, female ; HAM-D, Hamilton depression inventory; M, male; MDD, major depressive disorder; NA, not available; OCD, obsessive compulsive disorder; YBOCS, Yale-Brown Obsessive Compulsive Scale.

a

As assessed at the time of recording.

b

As assessed at the preoperative baseline of the clinical study.

HHS Vulnerability Disclosure